Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Rouanne

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Cancer Discovery|August 5, 2020
Pegylated Engineered IL2 plus Anti-PD-1 Monoclonal Antibody: The Nectar Comes from the CombinationMathieu Rouanne, Laurence Zitvogel, Aurélien Marabelle
World Journal of Urology|November 3, 2020
PD-L1 testing in urothelial bladder cancer: essentials of clinical practiceMathieu Rouanne, Camélia Radulescu, Julien Adam, et al.
Critical Reviews in Oncology/Hematology|November 22, 2015
Novel therapeutic targets in advanced urothelial carcinomaMathieu Rouanne, Yohann Loriot, Thierry Lebret, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2023
Neo-Adjuvant immunotherapies: Bladder cancer as a platform for drug development targeting mucosal immunityRainjade Chung, James McKiernan, Nicholas Arpaia, et al.
Anti-Cancer Drugs|December 9, 2014
Parotid gland metastasis from prostate cancer: is docetaxel still the best treatment option?Carole Hélissey, Mathieu Rouanne, Francois-Xavier Arnaud, et al.
Nature Reviews. Urology|July 11, 2023
From mucosal infection to successful cancer immunotherapyAnne-Gaëlle Goubet, Mathieu Rouanne, Lisa Derosa, et al.
Diseases of the Colon and Rectum|July 7, 2011
Outcome of a modified York Mason technique in men with iatrogenic urethrorectal fistula after radical prostatectomyMathieu Rouanne, Christophe Vaessen, Marc-Olivier Bitker, et al.
BJU International|November 4, 2010
Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imagingNicolas Barry Delongchamps, Mathieu Rouanne, Thierry Flam, et al.
European Urology|September 15, 2018
Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 TumorsTuan Zea Tan, Mathieu Rouanne, Kien Thiam Tan, et al.
Therapeutic Advances in Urology|July 11, 2015
Efficacy of triptorelin pamoate 11.25 mg administered subcutaneously for achieving medical castration levels of testosterone in patients with locally advanced or metastatic prostate cancerThiery Lebret, Mathieu Rouanne, Oleg Hublarov, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Cancer Discovery|August 5, 2020
Pegylated Engineered IL2 plus Anti-PD-1 Monoclonal Antibody: The Nectar Comes from the CombinationMathieu Rouanne, Laurence Zitvogel, Aurélien Marabelle
World Journal of Urology|November 3, 2020
PD-L1 testing in urothelial bladder cancer: essentials of clinical practiceMathieu Rouanne, Camélia Radulescu, Julien Adam, et al.
Critical Reviews in Oncology/Hematology|November 22, 2015
Novel therapeutic targets in advanced urothelial carcinomaMathieu Rouanne, Yohann Loriot, Thierry Lebret, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2023
Neo-Adjuvant immunotherapies: Bladder cancer as a platform for drug development targeting mucosal immunityRainjade Chung, James McKiernan, Nicholas Arpaia, et al.
Anti-Cancer Drugs|December 9, 2014
Parotid gland metastasis from prostate cancer: is docetaxel still the best treatment option?Carole Hélissey, Mathieu Rouanne, Francois-Xavier Arnaud, et al.
Nature Reviews. Urology|July 11, 2023
From mucosal infection to successful cancer immunotherapyAnne-Gaëlle Goubet, Mathieu Rouanne, Lisa Derosa, et al.
Diseases of the Colon and Rectum|July 7, 2011
Outcome of a modified York Mason technique in men with iatrogenic urethrorectal fistula after radical prostatectomyMathieu Rouanne, Christophe Vaessen, Marc-Olivier Bitker, et al.
BJU International|November 4, 2010
Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imagingNicolas Barry Delongchamps, Mathieu Rouanne, Thierry Flam, et al.
European Urology|September 15, 2018
Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 TumorsTuan Zea Tan, Mathieu Rouanne, Kien Thiam Tan, et al.
Therapeutic Advances in Urology|July 11, 2015
Efficacy of triptorelin pamoate 11.25 mg administered subcutaneously for achieving medical castration levels of testosterone in patients with locally advanced or metastatic prostate cancerThiery Lebret, Mathieu Rouanne, Oleg Hublarov, et al.
Pageof 6